4//SEC Filing
MATEON THERAPEUTICS INC 4
Accession 0001209191-17-003702
$OTLCCIK 0000908259operating
Filed
Jan 12, 7:00 PM ET
Accepted
Jan 13, 5:01 PM ET
Size
5.8 KB
Accession
0001209191-17-003702
Insider Transaction Report
Form 4
LOAR MATTHEW M
Chief Financial Officer
Transactions
- Award
Employee Stock Option (Right to Buy)
2017-01-12$0.38/sh+350,000$131,250→ 350,000 totalExercise: $0.38Exp: 2027-01-12→ Common Stock (350,000 underlying)
Footnotes (2)
- [F1]Mr. Loar was awarded options to purchase shares of Mateon Therapeutics, Inc. common stock, $0.01 par value per share, pursuant to the Mateon Therapeutics, Inc. 2017 Equity Incentive Plan in connection with his service as Chief Financial Officer.
- [F2]The Options will vest in forty-eight equal monthly installments beginning one month after the grant date.
Documents
Issuer
MATEON THERAPEUTICS INC
CIK 0000908259
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000908259
Filing Metadata
- Form type
- 4
- Filed
- Jan 12, 7:00 PM ET
- Accepted
- Jan 13, 5:01 PM ET
- Size
- 5.8 KB